- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The IBS-C Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global IBS-C Drug size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global IBS-C Drug market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
IBS-C Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Linaclotide
Lubiprostone
Osmotic Laxatives
Stimulant Laxatives
Other
Market segment by Application can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
The key market players for global IBS-C Drug market are listed below:
Catalent Pharmaceuticals Solutions
Nestle
Abbott Laboratories
Synergy Pharmaceuticals
Sucampo Pharmaceuticals
Novartis Pharma
Astellas Pharmaceuticals
Ardelyx
Synthetic Biologics
Teva Pharmaceutical Industries
Bama-Geve
Ferring BV
Ironwood Pharmaceuticals
Salix Pharmaceuticals
Norgine
Prometheus Laboratories
Actavis Nordic
Albireo Pharma
Yuhan Corp
Astrazeneca
The Menarini Group
Ono Pharmaceutical
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe IBS-C Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of IBS-C Drug, with price, sales, revenue and global market share of IBS-C Drug from 2019 to 2021.
Chapter 3, the IBS-C Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the IBS-C Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and IBS-C Drug market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe IBS-C Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 IBS-C Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global IBS-C Drug Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Linaclotide
1.2.3 Lubiprostone
1.2.4 Osmotic Laxatives
1.2.5 Stimulant Laxatives
1.2.6 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global IBS-C Drug Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global IBS-C Drug Market Size & Forecast
1.4.1 Global IBS-C Drug Sales in Value (2016-2026))
1.4.2 Global IBS-C Drug Sales in Volume (2016-2026)
1.4.3 Global IBS-C Drug Price by Type (2016-2026) & (USD/Unit)
1.5 Global IBS-C Drug Production Capacity Analysis
1.5.1 Global IBS-C Drug Total Production Capacity (2016-2026)
1.5.2 Global IBS-C Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 IBS-C Drug Market Drivers
1.6.2 IBS-C Drug Market Restraints
1.6.3 IBS-C Drug Trends Analysis
2 Manufacturers Profiles
2.1 Catalent Pharmaceuticals Solutions
2.1.1 Catalent Pharmaceuticals Solutions Details
2.1.2 Catalent Pharmaceuticals Solutions Major Business
2.1.3 Catalent Pharmaceuticals Solutions IBS-C Drug Product and Services
2.1.4 Catalent Pharmaceuticals Solutions IBS-C Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Nestle
2.2.1 Nestle Details
2.2.2 Nestle Major Business
2.2.3 Nestle IBS-C Drug Product and Services
2.2.4 Nestle IBS-C Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Abbott Laboratories
2.3.1 Abbott Laboratories Details
2.3.2 Abbott Laboratories Major Business
2.3.3 Abbott Laboratories IBS-C Drug Product and Services
2.3.4 Abbott Laboratories IBS-C Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Synergy Pharmaceuticals
2.4.1 Synergy Pharmaceuticals Details
2.4.2 Synergy Pharmaceuticals Major Business
2.4.3 Synergy Pharmaceuticals IBS-C Drug Product and Services
2.4.4 Synergy Pharmaceuticals IBS-C Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Sucampo Pharmaceuticals
2.5.1 Sucampo Pharmaceuticals Details
2.5.2 Sucampo Pharmaceuticals Major Business
2.5.3 Sucampo Pharmaceuticals IBS-C Drug Product and Services
2.5.4 Sucampo Pharmaceuticals IBS-C Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Novartis Pharma
2.6.1 Novartis Pharma Details
2.6.2 Novartis Pharma Major Business
2.6.3 Novartis Pharma IBS-C Drug Product and Services
2.6.4 Novartis Pharma IBS-C Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Astellas Pharmaceuticals
2.7.1 Astellas Pharmaceuticals Details
2.7.2 Astellas Pharmaceuticals Major Business
2.7.3 Astellas Pharmaceuticals IBS-C Drug Product and Services
2.7.4 Astellas Pharmaceuticals IBS-C Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Ardelyx
2.8.1 Ardelyx Details
2.8.2 Ardelyx Major Business
2.8.3 Ardelyx IBS-C Drug Product and Services
2.8.4 Ardelyx IBS-C Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Synthetic Biologics
2.9.1 Synthetic Biologics Details
2.9.2 Synthetic Biologics Major Business
2.9.3 Synthetic Biologics IBS-C Drug Product and Services
2.9.4 Synthetic Biologics IBS-C Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Teva Pharmaceutical Industries
2.10.1 Teva Pharmaceutical Industries Details
2.10.2 Teva Pharmaceutical Industries Major Business
2.10.3 Teva Pharmaceutical Industries IBS-C Drug Product and Services
2.10.4 Teva Pharmaceutical Industries IBS-C Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Bama-Geve
2.11.1 Bama-Geve Details
2.11.2 Bama-Geve Major Business
2.11.3 Bama-Geve IBS-C Drug Product and Services
2.11.4 Bama-Geve IBS-C Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Ferring BV
2.12.1 Ferring BV Details
2.12.2 Ferring BV Major Business
2.12.3 Ferring BV IBS-C Drug Product and Services
2.12.4 Ferring BV IBS-C Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Ironwood Pharmaceuticals
2.13.1 Ironwood Pharmaceuticals Details
2.13.2 Ironwood Pharmaceuticals Major Business
2.13.3 Ironwood Pharmaceuticals IBS-C Drug Product and Services
2.13.4 Ironwood Pharmaceuticals IBS-C Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 Salix Pharmaceuticals
2.14.1 Salix Pharmaceuticals Details
2.14.2 Salix Pharmaceuticals Major Business
2.14.3 Salix Pharmaceuticals IBS-C Drug Product and Services
2.14.4 Salix Pharmaceuticals IBS-C Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.15 Norgine
2.15.1 Norgine Details
2.15.2 Norgine Major Business
2.15.3 Norgine IBS-C Drug Product and Services
2.15.4 Norgine IBS-C Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.16 Prometheus Laboratories
2.16.1 Prometheus Laboratories Details
2.16.2 Prometheus Laboratories Major Business
2.16.3 Prometheus Laboratories IBS-C Drug Product and Services
2.16.4 Prometheus Laboratories IBS-C Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.17 Actavis Nordic
2.17.1 Actavis Nordic Details
2.17.2 Actavis Nordic Major Business
2.17.3 Actavis Nordic IBS-C Drug Product and Services
2.17.4 Actavis Nordic IBS-C Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.18 Albireo Pharma
2.18.1 Albireo Pharma Details
2.18.2 Albireo Pharma Major Business
2.18.3 Albireo Pharma IBS-C Drug Product and Services
2.18.4 Albireo Pharma IBS-C Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.19 Yuhan Corp
2.19.1 Yuhan Corp Details
2.19.2 Yuhan Corp Major Business
2.19.3 Yuhan Corp IBS-C Drug Product and Services
2.19.4 Yuhan Corp IBS-C Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.20 Astrazeneca
2.20.1 Astrazeneca Details
2.20.2 Astrazeneca Major Business
2.20.3 Astrazeneca IBS-C Drug Product and Services
2.20.4 Astrazeneca IBS-C Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.21 The Menarini Group
2.21.1 The Menarini Group Details
2.21.2 The Menarini Group Major Business
2.21.3 The Menarini Group IBS-C Drug Product and Services
2.21.4 The Menarini Group IBS-C Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.22 Ono Pharmaceutical
2.22.1 Ono Pharmaceutical Details
2.22.2 Ono Pharmaceutical Major Business
2.22.3 Ono Pharmaceutical IBS-C Drug Product and Services
2.22.4 Ono Pharmaceutical IBS-C Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 IBS-C Drug Sales by Manufacturer
3.1 Global IBS-C Drug Sales in Volume by Manufacturer (2019-2021e)
3.2 Global IBS-C Drug Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in IBS-C Drug
3.4 Market Concentration Rate
3.4.1 Top 3 IBS-C Drug Manufacturer Market Share
3.4.2 Top 6 IBS-C Drug Manufacturer Market Share
3.5 Global IBS-C Drug Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and IBS-C Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global IBS-C Drug Market Size by Region
4.1.1 Global IBS-C Drug Sales in Volume by Region (2016-2026)
4.1.2 Global IBS-C Drug Revenue by Region (2016-2026)
4.2 North America IBS-C Drug Revenue (2016-2026)
4.3 Europe IBS-C Drug Revenue (2016-2026)
4.4 Asia-Pacific IBS-C Drug Revenue (2016-2026)
4.5 South America IBS-C Drug Revenue (2016-2026)
4.6 Middle East and Africa IBS-C Drug Revenue (2016-2026)
5 Market Segment by Type
5.1 Global IBS-C Drug Sales in Volume by Type (2016-2026)
5.2 Global IBS-C Drug Revenue by Type (2016-2026)
5.3 Global IBS-C Drug Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global IBS-C Drug Sales in Volume by Application (2016-2026)
6.2 Global IBS-C Drug Revenue by Application (2016-2026)
6.3 Global IBS-C Drug Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America IBS-C Drug Sales by Type (2016-2026)
7.2 North America IBS-C Drug Sales by Application (2016-2026)
7.3 North America IBS-C Drug Market Size by Country
7.3.1 North America IBS-C Drug Sales in Volume by Country (2016-2026)
7.3.2 North America IBS-C Drug Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe IBS-C Drug Sales by Type (2016-2026)
8.2 Europe IBS-C Drug Sales by Application (2016-2026)
8.3 Europe IBS-C Drug Market Size by Country
8.3.1 Europe IBS-C Drug Sales in Volume by Country (2016-2026)
8.3.2 Europe IBS-C Drug Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific IBS-C Drug Sales by Type (2016-2026)
9.2 Asia-Pacific IBS-C Drug Sales by Application (2016-2026)
9.3 Asia-Pacific IBS-C Drug Market Size by Region
9.3.1 Asia-Pacific IBS-C Drug Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific IBS-C Drug Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America IBS-C Drug Sales by Type (2016-2026)
10.2 South America IBS-C Drug Sales by Application (2016-2026)
10.3 South America IBS-C Drug Market Size by Country
10.3.1 South America IBS-C Drug Sales in Volume by Country (2016-2026)
10.3.2 South America IBS-C Drug Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa IBS-C Drug Sales by Type (2016-2026)
11.2 Middle East & Africa IBS-C Drug Sales by Application (2016-2026)
11.3 Middle East & Africa IBS-C Drug Market Size by Country
11.3.1 Middle East & Africa IBS-C Drug Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa IBS-C Drug Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 IBS-C Drug Typical Distributors
12.3 IBS-C Drug Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global IBS-C Drug Revenue by Type, (USD Million), 2021-2026
Table 2. Global IBS-C Drug Revenue by Application, (USD Million), 2021-2026
Table 3. Catalent Pharmaceuticals Solutions Basic Information, Manufacturing Base and Competitors
Table 4. Catalent Pharmaceuticals Solutions Major Business
Table 5. Catalent Pharmaceuticals Solutions IBS-C Drug Product and Services
Table 6. Catalent Pharmaceuticals Solutions IBS-C Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Nestle Basic Information, Manufacturing Base and Competitors
Table 8. Nestle Major Business
Table 9. Nestle IBS-C Drug Product and Services
Table 10. Nestle IBS-C Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 12. Abbott Laboratories Major Business
Table 13. Abbott Laboratories IBS-C Drug Product and Services
Table 14. Abbott Laboratories IBS-C Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Synergy Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 16. Synergy Pharmaceuticals Major Business
Table 17. Synergy Pharmaceuticals IBS-C Drug Product and Services
Table 18. Synergy Pharmaceuticals IBS-C Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Sucampo Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 20. Sucampo Pharmaceuticals Major Business
Table 21. Sucampo Pharmaceuticals IBS-C Drug Product and Services
Table 22. Sucampo Pharmaceuticals IBS-C Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Novartis Pharma Basic Information, Manufacturing Base and Competitors
Table 24. Novartis Pharma Major Business
Table 25. Novartis Pharma IBS-C Drug Product and Services
Table 26. Novartis Pharma IBS-C Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Astellas Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 28. Astellas Pharmaceuticals Major Business
Table 29. Astellas Pharmaceuticals IBS-C Drug Product and Services
Table 30. Astellas Pharmaceuticals IBS-C Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Ardelyx Basic Information, Manufacturing Base and Competitors
Table 32. Ardelyx Major Business
Table 33. Ardelyx IBS-C Drug Product and Services
Table 34. Ardelyx IBS-C Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Synthetic Biologics Basic Information, Manufacturing Base and Competitors
Table 36. Synthetic Biologics Major Business
Table 37. Synthetic Biologics IBS-C Drug Product and Services
Table 38. Synthetic Biologics IBS-C Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 40. Teva Pharmaceutical Industries Major Business
Table 41. Teva Pharmaceutical Industries IBS-C Drug Product and Services
Table 42. Teva Pharmaceutical Industries IBS-C Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Bama-Geve Basic Information, Manufacturing Base and Competitors
Table 44. Bama-Geve Major Business
Table 45. Bama-Geve IBS-C Drug Product and Services
Table 46. Bama-Geve IBS-C Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Ferring BV Basic Information, Manufacturing Base and Competitors
Table 48. Ferring BV Major Business
Table 49. Ferring BV IBS-C Drug Product and Services
Table 50. Ferring BV IBS-C Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Ironwood Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 52. Ironwood Pharmaceuticals Major Business
Table 53. Ironwood Pharmaceuticals IBS-C Drug Product and Services
Table 54. Ironwood Pharmaceuticals IBS-C Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Salix Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 56. Salix Pharmaceuticals Major Business
Table 57. Salix Pharmaceuticals IBS-C Drug Product and Services
Table 58. Salix Pharmaceuticals IBS-C Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Norgine Basic Information, Manufacturing Base and Competitors
Table 60. Norgine Major Business
Table 61. Norgine IBS-C Drug Product and Services
Table 62. Norgine IBS-C Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. Prometheus Laboratories Basic Information, Manufacturing Base and Competitors
Table 64. Prometheus Laboratories Major Business
Table 65. Prometheus Laboratories IBS-C Drug Product and Services
Table 66. Prometheus Laboratories IBS-C Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Actavis Nordic Basic Information, Manufacturing Base and Competitors
Table 68. Actavis Nordic Major Business
Table 69. Actavis Nordic IBS-C Drug Product and Services
Table 70. Actavis Nordic IBS-C Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. Albireo Pharma Basic Information, Manufacturing Base and Competitors
Table 72. Albireo Pharma Major Business
Table 73. Albireo Pharma IBS-C Drug Product and Services
Table 74. Albireo Pharma IBS-C Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 75. Yuhan Corp Basic Information, Manufacturing Base and Competitors
Table 76. Yuhan Corp Major Business
Table 77. Yuhan Corp IBS-C Drug Product and Services
Table 78. Yuhan Corp IBS-C Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 79. Astrazeneca Basic Information, Manufacturing Base and Competitors
Table 80. Astrazeneca Major Business
Table 81. Astrazeneca IBS-C Drug Product and Services
Table 82. Astrazeneca IBS-C Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 83. The Menarini Group Basic Information, Manufacturing Base and Competitors
Table 84. The Menarini Group Major Business
Table 85. The Menarini Group IBS-C Drug Product and Services
Table 86. The Menarini Group IBS-C Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 87. Ono Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 88. Ono Pharmaceutical Major Business
Table 89. Ono Pharmaceutical IBS-C Drug Product and Services
Table 90. Ono Pharmaceutical IBS-C Drug Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 91. Global IBS-C Drug Sales by Manufacturer (2019-2021e) & (K Units)
Table 92. Global IBS-C Drug Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 93. Market Position of Manufacturers in IBS-C Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 94. Global IBS-C Drug Production Capacity by Company, (K Units): 2020 VS 2021
Table 95. Head Office and IBS-C Drug Production Site of Key Manufacturer
Table 96. IBS-C Drug New Entrant and Capacity Expansion Plans
Table 97. IBS-C Drug Mergers & Acquisitions in the Past Five Years
Table 98. Global IBS-C Drug Sales by Region (2016-2021e) & (K Units)
Table 99. Global IBS-C Drug Sales by Region (2021-2026) & (K Units)
Table 100. Global IBS-C Drug Revenue by Region (2016-2021e) & (USD Million)
Table 101. Global IBS-C Drug Revenue by Region (2021-2026) & (USD Million)
Table 102. Global IBS-C Drug Sales by Type (2016-2021e) & (K Units)
Table 103. Global IBS-C Drug Sales by Type (2021-2026) & (K Units)
Table 104. Global IBS-C Drug Revenue by Type (2016-2021e) & (USD Million)
Table 105. Global IBS-C Drug Revenue by Type (2021-2026) & (USD Million)
Table 106. Global IBS-C Drug Price by Type (2016-2021e) & (USD/Unit)
Table 107. Global IBS-C Drug Price by Type (2021-2026) & (USD/Unit)
Table 108. Global IBS-C Drug Sales by Application (2016-2021e) & (K Units)
Table 109. Global IBS-C Drug Sales by Application (2021-2026) & (K Units)
Table 110. Global IBS-C Drug Revenue by Application (2016-2021e) & (USD Million)
Table 111. Global IBS-C Drug Revenue by Application (2021-2026) & (USD Million)
Table 112. Global IBS-C Drug Price by Application (2016-2021e) & (USD/Unit)
Table 113. Global IBS-C Drug Price by Application (2021-2026) & (USD/Unit)
Table 114. North America IBS-C Drug Sales by Country (2016-2021e) & (K Units)
Table 115. North America IBS-C Drug Sales by Country (2021-2026) & (K Units)
Table 116. North America IBS-C Drug Revenue by Country (2016-2021e) & (USD Million)
Table 117. North America IBS-C Drug Revenue by Country (2021-2026) & (USD Million)
Table 118. North America IBS-C Drug Sales by Type (2016-2021e) & (K Units)
Table 119. North America IBS-C Drug Sales by Type (2021-2026) & (K Units)
Table 120. North America IBS-C Drug Sales by Application (2016-2021e) & (K Units)
Table 121. North America IBS-C Drug Sales by Application (2021-2026) & (K Units)
Table 122. Europe IBS-C Drug Sales by Country (2016-2021e) & (K Units)
Table 123. Europe IBS-C Drug Sales by Country (2021-2026) & (K Units)
Table 124. Europe IBS-C Drug Revenue by Country (2016-2021e) & (USD Million)
Table 125. Europe IBS-C Drug Revenue by Country (2021-2026) & (USD Million)
Table 126. Europe IBS-C Drug Sales by Type (2016-2021e) & (K Units)
Table 127. Europe IBS-C Drug Sales by Type (2021-2026) & (K Units)
Table 128. Europe IBS-C Drug Sales by Application (2016-2021e) & (K Units)
Table 129. Europe IBS-C Drug Sales by Application (2021-2026) & (K Units)
Table 130. Asia-Pacific IBS-C Drug Sales by Region (2016-2021e) & (K Units)
Table 131. Asia-Pacific IBS-C Drug Sales by Region (2021-2026) & (K Units)
Table 132. Asia-Pacific IBS-C Drug Revenue by Region (2016-2021e) & (USD Million)
Table 133. Asia-Pacific IBS-C Drug Revenue by Region (2021-2026) & (USD Million)
Table 134. Asia-Pacific IBS-C Drug Sales by Type (2016-2021e) & (K Units)
Table 135. Asia-Pacific IBS-C Drug Sales by Type (2021-2026) & (K Units)
Table 136. Asia-Pacific IBS-C Drug Sales by Application (2016-2021e) & (K Units)
Table 137. Asia-Pacific IBS-C Drug Sales by Application (2021-2026) & (K Units)
Table 138. South America IBS-C Drug Sales by Country (2016-2021e) & (K Units)
Table 139. South America IBS-C Drug Sales by Country (2021-2026) & (K Units)
Table 140. South America IBS-C Drug Revenue by Country (2016-2021e) & (USD Million)
Table 141. South America IBS-C Drug Revenue by Country (2021-2026) & (USD Million)
Table 142. South America IBS-C Drug Sales by Type (2016-2021e) & (K Units)
Table 143. South America IBS-C Drug Sales by Type (2021-2026) & (K Units)
Table 144. South America IBS-C Drug Sales by Application (2016-2021e) & (K Units)
Table 145. South America IBS-C Drug Sales by Application (2021-2026) & (K Units)
Table 146. Middle East & Africa IBS-C Drug Sales by Country (2016-2021e) & (K Units)
Table 147. Middle East & Africa IBS-C Drug Sales by Country (2021-2026) & (K Units)
Table 148. Middle East & Africa IBS-C Drug Revenue by Country (2016-2021e) & (USD Million)
Table 149. Middle East & Africa IBS-C Drug Revenue by Country (2021-2026) & (USD Million)
Table 150. Middle East & Africa IBS-C Drug Sales by Type (2016-2021e) & (K Units)
Table 151. Middle East & Africa IBS-C Drug Sales by Type (2021-2026) & (K Units)
Table 152. Middle East & Africa IBS-C Drug Sales by Application (2016-2021e) & (K Units)
Table 153. Middle East & Africa IBS-C Drug Sales by Application (2021-2026) & (K Units)
Table 154. Direct Channel Pros & Cons
Table 155. Indirect Channel Pros & Cons
Table 156. IBS-C Drug Typical Distributors
Table 157. IBS-C Drug Typical Customers
List of Figures
Figure 1. IBS-C Drug Picture
Figure 2. Global IBS-C Drug Sales Market Share by Type in 2020
Figure 3. Linaclotide
Figure 4. Lubiprostone
Figure 5. Osmotic Laxatives
Figure 6. Stimulant Laxatives
Figure 7. Other
Figure 8. Global IBS-C Drug Sales Market Share by Application in 2020
Figure 9. Hospital Pharmacies
Figure 10. Retail Pharmacies
Figure 11. Online Pharmacies
Figure 12. Global IBS-C Drug Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 13. Global IBS-C Drug Market Size and Forecast (2016-2026) & (USD Million)
Figure 14. Global IBS-C Drug Sales (2016-2026) & (K Units)
Figure 15. Global IBS-C Drug Price by Type (2016-2026) & (USD/Unit)
Figure 16. Global IBS-C Drug Production Capacity (2016-2026) & (K Units)
Figure 17. Global IBS-C Drug Production Capacity by Geographic Region: 2020 VS 2021
Figure 18. IBS-C Drug Market Drivers
Figure 19. IBS-C Drug Market Restraints
Figure 20. IBS-C Drug Market Trends
Figure 21. Global IBS-C Drug Sales Market Share by Manufacturer in 2020
Figure 22. Global IBS-C Drug Revenue Market Share by Manufacturer in 2020
Figure 23. IBS-C Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 24. Top 3 IBS-C Drug Manufacturer (Revenue) Market Share in 2020
Figure 25. Top 6 IBS-C Drug Manufacturer (Revenue) Market Share in 2020
Figure 26. Global IBS-C Drug Sales Market Share by Region (2016-2026)
Figure 27. Global IBS-C Drug Revenue Market Share by Region (2016-2026)
Figure 28. North America IBS-C Drug Revenue (2016-2026) & (USD Million)
Figure 29. Europe IBS-C Drug Revenue (2016-2026) & (USD Million)
Figure 30. Asia-Pacific IBS-C Drug Revenue (2016-2026) & (USD Million)
Figure 31. South America IBS-C Drug Revenue (2016-2026) & (USD Million)
Figure 32. Middle East & Africa IBS-C Drug Revenue (2016-2026) & (USD Million)
Figure 33. Global IBS-C Drug Sales Market Share by Type (2016-2026)
Figure 34. Global IBS-C Drug Revenue Market Share by Type (2016-2026)
Figure 35. Global IBS-C Drug Price by Type (2016-2026) & (USD/Unit)
Figure 36. Global IBS-C Drug Sales Market Share by Application (2016-2026)
Figure 37. Global IBS-C Drug Revenue Market Share by Application (2016-2026)
Figure 38. Global IBS-C Drug Price by Application (2016-2026) & (USD/Unit)
Figure 39. North America IBS-C Drug Sales Market Share by Type (2016-2026)
Figure 40. North America IBS-C Drug Sales Market Share by Application (2016-2026)
Figure 41. North America IBS-C Drug Sales Market Share by Country (2016-2026)
Figure 42. North America IBS-C Drug Revenue Market Share by Country (2016-2026)
Figure 43. United States IBS-C Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Canada IBS-C Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Mexico IBS-C Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Europe IBS-C Drug Sales Market Share by Type (2016-2026)
Figure 47. Europe IBS-C Drug Sales Market Share by Application (2016-2026)
Figure 48. Europe IBS-C Drug Sales Market Share by Country (2016-2026)
Figure 49. Europe IBS-C Drug Revenue Market Share by Country (2016-2026)
Figure 50. Germany IBS-C Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France IBS-C Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom IBS-C Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia IBS-C Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy IBS-C Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific IBS-C Drug Sales Market Share by Region (2016-2026)
Figure 56. Asia-Pacific IBS-C Drug Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific IBS-C Drug Sales Market Share by Region (2016-2026)
Figure 58. Asia-Pacific IBS-C Drug Revenue Market Share by Region (2016-2026)
Figure 59. China IBS-C Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan IBS-C Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Korea IBS-C Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India IBS-C Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia IBS-C Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia IBS-C Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America IBS-C Drug Sales Market Share by Type (2016-2026)
Figure 66. South America IBS-C Drug Sales Market Share by Application (2016-2026)
Figure 67. South America IBS-C Drug Sales Market Share by Country (2016-2026)
Figure 68. South America IBS-C Drug Revenue Market Share by Country (2016-2026)
Figure 69. Brazil IBS-C Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Argentina IBS-C Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Middle East & Africa IBS-C Drug Sales Market Share by Type (2016-2026)
Figure 72. Middle East & Africa IBS-C Drug Sales Market Share by Application (2016-2026)
Figure 73. Middle East & Africa IBS-C Drug Sales Market Share by Country (2016-2026)
Figure 74. Middle East & Africa IBS-C Drug Revenue Market Share by Country (2016-2026)
Figure 75. Turkey IBS-C Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Egypt IBS-C Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Saudi Arabia IBS-C Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. South Africa IBS-C Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
